文献速递艾滋病与性传播感染

司美格鲁肽对HIV感染者认知功能的影响:一项随机对照试验

Effects of Semaglutide on Cognitive Function in People With HIV: A Randomized, Controlled Trial.
PubMed 文献 · Clin Infect Dis · 2026-01-01

本研究为随机双盲安慰剂对照2b期试验,108名接受抗逆转录病毒治疗的HIV感染者按1:1随机接受32周皮下司美格鲁肽或安慰剂。结果显示司美格鲁肽显著改善视空间、命名/语言和延迟回忆评分,但调整性别和CD4后仅视空间评分保持显著。中介分析提示其对视空间认知的改善可能通过炎症途径介导。

要点

  • 司美格鲁肽可能改善HIV感染者视空间认知功能。
  • 调整性别和CD4后仅视空间评分差异显著。
  • 炎症标志物变化可能介导该认知获益。

核心结论

  • 司美格鲁肽可能通过抗炎作用对HIV感染者的视空间认知功能产生有益影响。

研究设计与样本

  • 随机双盲安慰剂对照2b期临床试验,108名接受抗逆转录病毒治疗的HIV感染者按1:1随机接受32周皮下司美格鲁肽或安慰剂。

临床怎么用

  • 对于接受抗逆转录病毒治疗的HIV感染者,司美格鲁肽可能作为改善视空间认知的潜在选择,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People with human immunodeficiency virus (HIV, PWH) are at higher risk for visceral adiposity, enhanced inflammation, and cognitive decline than controls who do not have HIV. We previously demonstrated that PWH with lipohypertrophy had a decrease in weight, visceral adipose tissue, and several inflammatory markers after receiving semaglutide, a glucagon-like peptide-1 receptor agonist. Our aim was to investigate the effect of semaglutide on cognitive function in PWH and the possible mediation of this effect by changes in adiposity or inflammation. METHODS: In this randomized, double-blind, placebo-controlled phase 2b clinical trial, PWH on antiretroviral therapy were randomized 1:1 to receive 32 weeks of subcutaneous semaglutide or placebo. The primary outcome was the change in cognitive function at 32 weeks. Secondary measures included changes in body composition and inflammatory markers. Causal mediation analysis assessed semaglutide's direct and indirect effects on Cognivue scores through changes in adiposity and inflammation. RESULTS: 108 participants were included (54 per arm); 65% were non-White, 40% were female, and median age was 53 years. Compared with placebo, PWH on semaglutide significantly increased visuospatial, naming/language, and delayed recall scores at 32 weeks (P = .01, .05, and .04, respectively). After adjusting for sex and absolute CD4 count, only visuospatial score remained statistically significant (P = .05). Semaglutide's total natural direct effect maintained a positive effect on the visuospatial score while accounting for potential changes in high-sensitivity C-reactive protein and soluble CD163 levels (P = .04). CONCLUSIONS: Semaglutide may have a beneficial impact on visuospatial cognitive function in PWH through its effect on inflammation. Clinical Trials Registration . NCT04019197.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Atieh O, Daher J, Abboud M, et al. Effects of Semaglutide on Cognitive Function in People With HIV: A Randomized, Controlled Trial. Clin Infect Dis. 2026. PMID: 41098140. doi:10.1093/cid/ciaf577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。